IN-1130, a Novel Transforming Growth Factor-β Type I Receptor Kinase (Activin Receptor-like Kinase 5) Inhibitor, Promotes Regression of Fibrotic Plaque and Corrects Penile Curvature in a Rat Model of Peyronie’s Disease - Concepedia

Concepedia

Publication | Closed Access

IN-1130, a Novel Transforming Growth Factor-β Type I Receptor Kinase (Activin Receptor-like Kinase 5) Inhibitor, Promotes Regression of Fibrotic Plaque and Corrects Penile Curvature in a Rat Model of Peyronie’s Disease

47

Citations

28

References

2009

Year

Ji‐Kan Ryu, Shuguang Piao, Hwa‐Yean Shin, Min Ji Choi, Lu Wei Zhang, Hai‐Rong Jin, Woo Jean Kim, Jee‐Young Han, Soon Sun Hong, Seok Hee Park,

The Journal of Sexual Medicine

Abstract

Antagonizing TGF-beta signaling through the use of ALK5 inhibitors may represent an exciting new therapeutic strategy for the future treatment of PD.

References

	Year	Citations

Page 1